Federal Xarelto Lawsuits Move Forward, as Third Bellwether Case Heads to Trial in Mississippi, Bernstein Liebhard LLP Reports

NEW YORK, Aug. 14, 2017 /PRNewswire/ -- The federal litigation established for Xarelto lawsuits in the U.S. District Court, Eastern District of Louisiana, continues to move forward. According to court records, the proceeding's third bellwether trial is now underway in Mississippi, following the completion of jury selection on August 7^th. (In Re: Xarelto Products Liability Litigation, No. 2592)

"Our Firm is representing many Xarelto plaintiffs who allegedly experienced life-threating internal bleeding due to treatment with this medication. The verdict in this case could provide insight into other jury decisions in similar claims, so our attorneys will be monitoring developments closely," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm continues to evaluate potential Xarelto lawsuits on behalf of individuals who may have been harmed by this blood-thinning medication.

Xarelto Litigation

Xarelto is a new-generation blood thinner jointly marketed by Bayer and Johnson & Johnson. Approved by the U.S. Food & Drug Administration (FDA) in October 2011, Xarelto is currently indicated for the prevention of strokes in people with atrial fibrillation; the treatment of deep vein thrombosis and pulmonary embolism; and the prevention of deep vein thrombosis in patients undergoing hip or knee implant surgery.

Nearly 18,000 Xarelto lawsuits are pending in the District of Louisiana, where all federally-filed product liability lawsuits involving the medication have been centralized for the purpose of coordinated pretrial proceedings. Plaintiffs involved in this litigation claim that the drug's manufacturers failed to provide doctors and patients with adequate warnings regarding uncontrollable bleeding that may occur with Xarelto, and wrongly promoted the blood thinner as a superior alternative to warfarin. Among other things, their lawsuits note that internal bleeding associated with warfarin can be reversed via the administration of vitamin K. However, there is currently no approved antidote to stop episodes of Xarelto internal bleeding. 

The Xarelto lawsuit selected for the litigation's third bellwether trial was filed on behalf of a Mississippi woman, and is thus being heard in the U.S. District Court, Southern District of Mississippi. The plaintiff in the case was prescribed Xarelto after she developed a deep vein thrombosis following hip replacement surgery. She alleges that the drug subsequently caused her to suffer a severe gastrointestinal bleed.

The first two Xarelto bellwether trials were heard in the Eastern District of Louisiana, and concluded with defense verdicts. A fourth case is scheduled for trial in January in Texas federal court.

Xarelto patients who allegedly experienced bleeding-related complications may be entitled to compensation for their medical bills, lost wages, pain and suffering, and more. To learn more about filing a Xarelto lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.

Bernstein Liebhard LLP 
10 East 40th Street 
New York, New York 10016 
800-511-5092

ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information: 
Sandy A. Liebhard, Esq. 
Bernstein Liebhard LLP 
info (at)consumerinjurylawyers(dot)com
http://www.rxinjuryhelp.com/

SOURCE Bernstein Liebhard LLP

Related Links

http://www.bernlieb.com